Therefore, MV4-11 AML cancer cell line, a FLT3-positive cell line which exhibits multidrug resistance [34], was included in our experimental system to investigate the mechanism of ADR’s anticancer activity, especially ADR’s effect on multidrug resistant cancer cells. Here, FLT3 is linked to cancer.